Finance

Lists
Why is RNXT up 3.39%?
Dive Deeper
RNXT:NASDAQ
RenovoRx Inc
$1.22
+3.39%
(+0.040) 1D
$1.20
-1.64% (-0.020)
After hours
Closed: Nov 11, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RNXT...
Open
$1.15
High
$1.26
Low
$1.12
Mkt. cap
58.87M
Avg. vol.
451.66K
Volume
0.00
52-wk high
$2.59
52-wk low
$0.70
EPS
-$0.31
Beta
1.12
Shares outstanding
48.25M
No. of employees
17
Open
$1.15
High
$1.26
Low
$1.12
Mkt. cap
58.87M
Avg. vol.
451.66K
Volume
0.00
52-wk high
$2.59
52-wk low
$0.70
EPS
-$0.31
Beta
1.12
Shares outstanding
48.25M
No. of employees
17
News stories
From web sources and news partners
About RenovoRx Inc
CEO-
Employees17
Founded2009
Headquarters-
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 4 analysts giving stock ratings to RNXT in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for RNXT in the last 3 months.
Highest
Current $1.22
$14.50 (+1,088.52%)
Average
$7.13 (+484.43%)
Lowest
$3.00 (+145.90%)
Analyst
Recommendation
Action
Price target
Projected
Date
Justin Walsh
JonesTrading
Buy
Reiterated
$8.00
+555.7%
11/09/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Maintained
$3.00
+145.9%
11/06/2026
Edward Woo
Ascendiant
Buy
Maintained
$14.50
+1,088.5%
08/27/2026
Scott Henry
Alliance Global Partners
Buy
Maintained
$3.00
+145.9%
08/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
238.00K
563.00K
909.00K
1.07M
Cost of goods sold
28.00K
84.00K
143.00K
188.00K
Cost of revenue
28.00K
84.00K
143.00K
188.00K
Research and development expenses
1.00M
1.23M
1.20M
1.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.23M
2.72M
2.92M
2.87M
Operating expense
3.23M
3.95M
4.12M
4.11M
Total operating expenses
3.26M
4.03M
4.26M
4.30M
Operating income
-3.02M
-3.47M
-3.35M
-3.24M
Other non operating income
506.00K
-97.00K
350.00K
-487.00K
EBT including unusual items
-2.94M
-3.52M
-2.91M
-3.65M
EBT excluding unusual items
-2.44M
-3.52M
-2.91M
-3.65M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.94M
-3.52M
-2.91M
-3.65M
Net profit margin
-1,235.71%
-625.40%
-320.24%
-342.12%
Earnings per share
-0.08
-0.08
-0.05
-0.07
Interest and investment income
75.00K
45.00K
90.00K
76.00K
Interest expense
-
-
-
-
Net interest expenses
75.00K
45.00K
90.00K
76.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.02M
-3.47M
-3.34M
-3.23M
Gain or loss from assets sale
-
-
2.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps